<div>Section I: The Core Needle Biopsy Program</div><div><br></div><div>1 Essential Components of a Successful Breast Core Needle Biopsy Program: Imaging Modalities, Sampling Techniques, Specimen Processing, Radiologic/Pathologic Correlation, and Appropriate Follow-Up</div><div>Christine M. Denison and Susan Lester</div><div><br></div><div>Section II: Instructive Topics Toward Diagnosis in Core Biopsy Samples</div><div><br></div><div>2 Pattern Based Evaluation of Breast Core Needle Biopsies</div><div>Sandra J. Shin, Paula S. Ginter</div><div><br></div><div>3 Multiples in Core Biopsy Samples</div><div>Sandra J. Shin, Paula S. Ginter</div><div><br></div><div>Section III: Specific Entities Sampled in Core Biopsies</div><div><br></div><div>4 Inflammatory, Reactive, and Infectious Conditions of the Breast</div><div>Timothy M. D’Alfonso</div><div><br></div><div>5 Adenosis, Sclerosing Lesions, Microglandular Adenosis and Mucocele-Like Lesions</div><div>Beth T. Harrison and Deborah A. Dillon6 Papillary and Adenomyoepithelial Tumors</div><div>Daniel W. Visscher, Timothy M. D’Alfonso, and Sandra J. Shin</div><div><br></div><div>7 Fibroepithelial Lesions in Women, Adolescents/Children and Males</div><div>Gregor Krings and Yunn-Yi Chen</div><div><br></div><div>8 The Spectrum of Columnar Cell Lesions</div><div>Timothy M. D’Alfonso and Daniel W. Visscher</div><div><br></div><div>9 Intra-Ductal Proliferations (DCIS, ADH and UDH)</div><div>Kimberly H. Allison and Kristin C. Jensen</div><div><br></div><div>10 Invasive Ductal Carcinoma Including Microinvasive Carcinoma, Tubular Carcinoma and Cribriform Carcinoma</div><div>Karan Saluja, Helena Hwang, and Sunati Sahoo</div><div><br></div><div>11 Triple Negative/Basal-like Breast Carcinomas</div><div>Benjamin C. Calhoun and Laura C. Collins</div><div><br></div><div>12 Less Common Triple Negative Breast Cancer</div><div>Poonam Vohra, Gregor Krings, and Yunn-Yi Chen</div><div><br></div><div>13 Special Histologic Types of Breast Cancer: Mucinous, Secretory, Micropapillary, Neuroendocrine, Cystic Hypersecretory, Glycogen-Rich Clear Cell, and Carcinoma with Osteoclast-Like Giant Cells</div><div>Yun Wu, Sandra J. Shin, and Aysegul A. Sahin</div><div><br></div><div>14 Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ</div><div>Helena Hwang and Sunati Sahoo</div><div><br></div><div>15 Invasive Lobular Carcinoma</div><div>Helena Hwang and Sunati Sahoo</div><div><br></div><div>16 Benign and Malignant Mesenchymal Tumors</div><div>Ashley Cimino-Mathews, Susan C. Harvey, and Pedram Argani</div><div><br></div><div>17 Vascular Lesions of the Breast</div><div>Melinda E. Sanders, Jean F. Simpson, and Justin M. M. Cates</div><div><br></div><div>18 Breast Tumors in Adolescents/Children and Males</div><div>Melinda E. Sanders and Jean F. Simpson</div><div><br></div><div>Section IV: Special Considerations in Core Biopsies</div><div><br></div><div>19 Lesions of the Nipple</div><div>Nicole Johnson and Laura C. Collins<div><br><div>20 Lymphoid and Hematopoietic Tumors of the Breast</div><div>Julia Turbiner Geyer</div><div><br></div><div>21 Special Clinical Settings: Tumors Arising in Pregnancy, Pregnancy-Like (Pseudolactational) Proliferations, Breast Carcinoma in the Pre-Neoadjuvant Chemotherapy Setting, Recurrent Breast Carcinoma, Inflammatory Breast Carcinoma</div><div>Paula S. Ginter, Mamatha Chivukula, and Sandra J. Shin</div><div><br></div><div>22 Current Standard Clinical Predictive Markers</div><div>Kristin C. Jensen and Kimberly H. Allison</div><div><br></div><div>23 Future Role of Molecular Profiling in Small Breast Samples and Personalized Medicine</div><div>Sarah Sim, Peter T. Simpson, Margaret Cummings, and Sunil R. Lakhani</div><div><br></div><div>24 Metastases to the Breast</div><div>Ashley Cimino-Mathews, Susan C. Harvey, and Pedram Argani</div><div><br></div><div>25 Dermatologic Mimickers of Breast Lesions Arising in the Breast Skin, Subcutis or Axilla</div>t Desman, Lurmag Y. Orta, and Sandra J. Shin<div> </div></div></div>
